ATLAS VENTURE PARALLEL FUND V-B C V's Net Worth
$356 Million
Who is ATLAS VENTURE PARALLEL FUND V-B C V?
ATLAS VENTURE PARALLEL FUND V-B C V has an estimated net worth of $356 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., Phase Forward Inc, and MOMENTA PHARMACEUTICALS INC.
SEC CIK
ATLAS VENTURE PARALLEL FUND V-B C V's CIK is 0001133790
Past Insider Trading and Trends
2004 was ATLAS VENTURE PARALLEL FUND V-B C V's most active year for acquiring shares with 45 total transactions. ATLAS VENTURE PARALLEL FUND V-B C V's most active month to acquire stocks was the month of May. 2005 was ATLAS VENTURE PARALLEL FUND V-B C V's most active year for disposing of shares, totalling 39 transactions. ATLAS VENTURE PARALLEL FUND V-B C V's most active month to dispose stocks was the month of May. 2004 saw ATLAS VENTURE PARALLEL FUND V-B C V paying a total of $6,926,000.00 for 12,062,158 shares, this is the most they've acquired in one year. In 2005 ATLAS VENTURE PARALLEL FUND V-B C V cashed out on 6,463,650 shares for a total of $8,966,824.76, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $169.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -33.33% | -1.34M |
—
|
—
| 2.67M |
Sep 29
| |||
Form 4
| +801.66% | 3.57M |
—
|
—
| 4.01M |
Jun 3
| |||
Form 4/A
|
∞
| 445K |
$6.00 | $2,670,000.00 | 445K |
May 27
| |||
Form 4
|
∞
| 445K |
$6.00 | $2,670,000.00 | 445K |
May 27 - Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Phase Forward Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -36.45% | -1.25M |
—
|
—
| 2.18M |
Oct 10
| |||
Form 4
| -5.25% | -190.00K |
$8.97 | -$1,704,300.00 | 3.43M |
Sep 14
| |||
Form 4
| -1.87% | -138.29K |
$8.46 | -$1,169,767.24 | 7.24M |
Sep 9 - Sep 12
| |||
Form 4
| -1.46% | -111.71K |
$8.27 | -$924,300.52 | 7.52M |
Sep 7 - Sep 8
| |||
Form 4
| -1.15% | -45.00K |
$7.61 | -$342,450.00 | 3.87M |
Jun 14
| |||
Form 4
| -1.26% | -50.00K |
$6.93 | -$346,500.00 | 3.91M |
Jun 9
| |||
Form 4
| -1.28% | -154.62K |
$6.82 | -$1,054,507.00 | 11.89M |
Jun 6 - Jun 8
| |||
Form 4
| -10.82% | -500.00K |
$6.85 | -$3,425,000.00 | 4.12M |
Mar 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
MOMENTA PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -19.16% | -1.17M |
—
|
—
| 4.92M |
Aug 3
| |||
Form 4
| -20.00% | -1.52M |
—
|
—
| 6.08M |
Jul 5
| |||
Form 4
| +3,016.71% | 7.36M |
—
|
—
| 7.6M |
Jun 25
| |||
Form 4
|
∞
| 244K |
$6.50 | $1,586,000.00 | 244K |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |